Literature DB >> 15193769

Prostaglandin E2 regulates amyloid precursor protein expression via the EP2 receptor in cultured rat microglia.

Amy M Pooler1, Anibal A Arjona, Robert K Lee, Richard J Wurtman.   

Abstract

We investigated the effects of prostaglandin E2 (PGE2) on amyloid precursor protein (APP) expression in cultured rat microglia. PGE2 treatment significantly increased the expression of APP holoprotein and was associated with an elevation in cyclic AMP (cAMP). Direct activation of adenylate cyclase with forskolin also increased APP expression. Co-treatment of microglia with PGE2 and the PKA inhibitor H-89 suppressed the overexpression of APP caused by PGE2 alone. The prostaglandin EP2 receptor is known to be positively coupled to cAMP production. Stimulation of the EP2 receptor with butaprost increased APP holoprotein, whereas co-incubation of the cells with PGE(2) and the EP2 receptor antagonist AH-6809 blocked the effect of PGE2 on APP expression. These data suggest that PGE2 is able to regulate the expression of APP, and that this effect may be mediated by the EP2 receptor and the cAMP signaling cascade. Copyright 2004 Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15193769     DOI: 10.1016/j.neulet.2004.03.013

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

Review 1.  The role of inflammatory processes in Alzheimer's disease.

Authors:  G Joseph Broussard; Jennifer Mytar; Rung-chi Li; Gloria J Klapstein
Journal:  Inflammopharmacology       Date:  2012-04-26       Impact factor: 4.473

2.  Prostaglandin E2 receptor subtype 2 regulation of scavenger receptor CD36 modulates microglial Aβ42 phagocytosis.

Authors:  Xianwu Li; Erica Melief; Nadia Postupna; Kathleen S Montine; C Dirk Keene; Thomas J Montine
Journal:  Am J Pathol       Date:  2014-11-15       Impact factor: 4.307

Review 3.  Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection.

Authors:  Jianxiong Jiang; Ray Dingledine
Journal:  Trends Pharmacol Sci       Date:  2013-06-21       Impact factor: 14.819

4.  Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder.

Authors:  Hanan Qasem; Laila Al-Ayadhi; Geir Bjørklund; Salvatore Chirumbolo; Afaf El-Ansary
Journal:  Metab Brain Dis       Date:  2018-03-22       Impact factor: 3.584

Review 5.  Neuroaxonal and cellular damage/protection by prostanoid receptor ligands, fatty acid derivatives and associated enzyme inhibitors.

Authors:  Najam A Sharif
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

Review 6.  Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.

Authors:  Eiron Cudaback; Nikolas L Jorstad; Yue Yang; Thomas J Montine; C Dirk Keene
Journal:  Biochem Pharmacol       Date:  2014-01-13       Impact factor: 5.858

7.  Prostaglandin E2 stimulates the production of amyloid-beta peptides through internalization of the EP4 receptor.

Authors:  Tatsuya Hoshino; Takushi Namba; Masaya Takehara; Tadashi Nakaya; Yukihiko Sugimoto; Wataru Araki; Shuh Narumiya; Toshiharu Suzuki; Tohru Mizushima
Journal:  J Biol Chem       Date:  2009-04-30       Impact factor: 5.157

Review 8.  Roles of the prostaglandin E2 receptors EP subtypes in Alzheimer's disease.

Authors:  Li-Li Wei; Yue-Di Shen; Ying-Chun Zhang; Xing-Yue Hu; Pei-Ling Lu; Li Wang; Wei Chen
Journal:  Neurosci Bull       Date:  2010-02       Impact factor: 5.203

Review 9.  Role of prostaglandins in neuroinflammatory and neurodegenerative diseases.

Authors:  Isabel Vieira de Assis Lima; Leandro Francisco Silva Bastos; Marcelo Limborço-Filho; Bernd L Fiebich; Antonio Carlos Pinheiro de Oliveira
Journal:  Mediators Inflamm       Date:  2012-06-18       Impact factor: 4.711

10.  Gpr3 stimulates Aβ production via interactions with APP and β-arrestin2.

Authors:  Christopher D Nelson; Morgan Sheng
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.